SpaceX IPO launched today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
156.20    3.40 (2.23%)
Bid:
156.00
Ask:
156.40
Spread: 0.40 (0.256%)
Market Cap: £893.96m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Third Quarter Trading Update

29 Oct 2025 07:00

RNS Number : 1991F
Elementis PLC
29 October 2025
Β 

29 October 2025

Β 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 of 16 April 2014 which forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

Β 

Elementis plc

Third Quarter Trading Update

Β 

Resilient performance, full year guidance maintained

Β 

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues its scheduled trading update for the three months ended 30 September 2025 ("the quarter").

Despite the ongoing weak market conditions, the Group is on track to deliver full year financial performance in line with market expectations1, supported by our Elevate Elementis strategy and the positive changes being implemented across the Group.

Business performance

The Group delivered a resilient performance in the quarter, with revenue3 of c.$152m, up c.2% compared to the prior period. On a constant currency basis2 revenue was flat reflecting the impact of the weaker dollar.

Adjusted operating profit3 improved against the prior year, driven by self-help and cost-control actions. Year-to-date adjusted operating margins3 are consistent with the H1 performance.

Personal Care sales were flat on constant currency basis with positive price and volume impacts helping to offset the negative impact of mix in the period.

Coatings sales were flat on a constant currency basis due to volume and mix weakness in the Americas. This was offset partially by price improvements. The energy business continues to perform strongly with volumes, pricing and mix higher than the prior year period.

We are on track to deliver $12m in cost savings by end of this year that completes the $30m of cost savings announced in November 2023 for delivery by the end of 2025. In addition, as we drive simplification and agility across the business, we continue to expect around $5m of further savings this year. This is part of the $10m of additional savings to 2026 (net of additional R&D spend) that we announced in July with our Elevate Elementis strategy.

Eaglescliffe

On 14 October 2025, Elementis completed the sale of the disused manufacturing site at Eaglescliffe in the UK to Flacks Group resulting in a cash outflow of c.$11m.Β This follows recently obtained UK Environment Agency consent to the transfer of all operating permits to the buyer. This completes the exit for the Group from the Eaglescliffe site and the removal of c.$20m environmental liabilities from the balance sheet.Β 

Directorate changes

Following the successful completion of several significant milestones for the Group in his time as chair including the sale of the Chromium and Talc businesses, the appointment of Luc van Ravenstein as CEO and the launch of the new Elevate Elementis strategy in July, the Group's Chair, John O'Higgins, has informed the Board that he will not seek re-election at the Company's AGM on 29 April 2026 and will step down as Chair and NED immediately following the AGM. Further details on the Chair succession plan will be provided in due course.

Β 

In recognition of the need to transition to a Board that is more reflective of the reduced size of the business, the Group also announces today that Heejae Chae will be stepping down as NED at the end of this year.

Β 

On 30 September 2025, we announced that Ralph Hewins, CFO, would be retiring from the company after nine years in the role and will step down from his position at the end of 2025. The company also announced that Kath Kearney-Croft, had been appointed to succeed Ralph and will join as CFO designate on 3 November 2025 before becoming CFO and a member of the Elementis Board on 1 January 2026. Kath has been CFO of Learning Technologies Group since 2021, and prior to this has over 20 years of experience in a range of CFO and senior finance roles in the UK and US with SIG plc, The Vitec Group plc, Rexam PLC, and BOC Group.Β 

Β 

Luc van Ravenstein, CEO of Elementis, said:

"I am pleased to report that we have delivered a resilient third quarter performance, despite the continued softness in the coatings markets, demonstrating the strength and quality of our business and our commitment to delivering outstanding value for our customers. While revenue was broadly stable on the prior year period, our margins remain healthy due to the benefits of our proactive operational efficiency initiatives as we create a simpler, leaner Elementis. With market demand in coatings likely to remain soft, we remain focused on executing our Elevate Elementis strategy - designed to accelerate sustainable growth and deliver attractive returns."

Β 

John O'Higgins, Chair of Elementis, said:

"It's been an honour to serve as Chair of Elementis. The Company has navigated significant transformation during this time, and I'm incredibly proud of what we've achieved together in creating a more resilient and focused business. Following the successful completion of several milestones, now is the right time for me to step down and I look forward to continuing to support Luc and the rest of the Board until the next AGM. On behalf of the Board, I would also like to thank Heejae for his valuable contribution to the Board and its Committees during his tenure."

Β 

The person responsible for the release of this announcement on behalf of Elementis plc is Hannah Constantine, Group General Counsel and Company Secretary.

Β 

Enquiries

Investors: Zeeshan Maqbool, Elementis plc Tel: +44 7553 340380

Press: Martin Robinson/Giles Kernick, Teneo Tel: +44 (0) 20 7353 4200

Β 

Β 

Β 

Β Notes:

1. Based on company compiled consensus dated 28 October 2025, the mean adjusted operating profit for the year ended 31 December 2025 is $125m (range $123-127m).

2. Constant currency rates are determined as the reported rates excluding the impact of changes in the average translation exchange rates during the period.

3. Continuing operations basis.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTUWSARVRURUUA
Date   Source Headline
16th Jan 20251:45 pmRNSHolding(s) in Company
2nd Jan 202510:06 amRNSTotal Voting Rights
24th Dec 20247:00 amRNSDirectorate Change
9th Dec 20245:05 pmRNSDirector/PDMR Shareholding
2nd Dec 202410:06 amRNSTotal Voting Rights
18th Nov 20247:00 amRNSChief Executive Succession
1st Nov 20249:54 amRNSTotal Voting Rights
29th Oct 20247:00 amRNSThird Quarter Trading Update
11th Oct 202411:18 amRNSDirector/PDMR Shareholding
17th Sep 20248:50 amRNSDirector/PDMR Shareholding
2nd Sep 20249:31 amRNSBlock listing Interim Review
23rd Aug 202410:31 amRNSHolding(s) in Company
14th Aug 202410:53 amRNSAdditional Listing
9th Aug 20242:43 pmRNSHolding(s) in Company
2nd Aug 20245:44 pmRNSHolding(s) in Company
1st Aug 20243:10 pmRNSCorrection of dividend record date
1st Aug 20247:00 amRNSHalf-year Report
15th Jul 202410:59 amRNSHolding(s) in Company
30th May 202412:52 pmRNSDirector/PDMR Shareholding
29th May 20241:07 pmRNSDirector Declaration
8th May 202411:08 amRNSDirector/PDMR Shareholding
3rd May 202411:46 amRNSHolding(s) in Company
1st May 202410:06 amRNSTotal Voting Rights
30th Apr 202411:36 amRNSResult of AGM
30th Apr 20247:00 amRNSFirst quarter trading update
29th Apr 202412:13 pmRNSResponse to open letter from Gatemore
12th Apr 202411:33 amRNSDirector/PDMR Shareholding
12th Apr 202411:28 amRNSDirector/PDMR Shareholding
9th Apr 20246:04 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSAnnual Financial Report & Notice of AGM
19th Mar 20243:02 pmRNSAdditional Listing
15th Mar 20241:00 pmRNSDirectorate Change
12th Mar 20244:38 pmRNSDirector/PDMR Shareholding
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
8th Mar 20245:56 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirectorate changes
7th Mar 20247:00 amRNSPreliminary results year ended 31 December 2023
1st Mar 20249:30 amRNSBlock listing Interim Review
18th Jan 20247:00 amRNSTrading Update
2nd Jan 20249:45 amRNSTotal Voting Rights
1st Dec 202310:46 amRNSTotal Voting Rights
30th Nov 20239:38 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNS2023 Capital Markets Day
1st Nov 20239:46 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSThird Quarter Trading Update
2nd Oct 20239:34 amRNSTotal Voting Rights
20th Sep 202312:09 pmRNSResponse to open letter from Franklin Templeton
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.